Literature DB >> 9180248

Leukocyte activation in atherosclerosis: correlation with risk factors.

A M Elneihoum1, P Falke, B Hedblad, F Lindgärde, K Ohlsson.   

Abstract

Leukocytes have been implicated in the development of atherosclerotic vascular diseases, and numerous abnormalities of leukocytes in conjunction with atherosclerosis have been reported. The aim of this study of middle-aged asymptomatic subjects with early atherosclerosis was to determine whether a relationship exists between the levels of plasma markers of leukocyte activation, i.e. cytokines and proteases and risk factors for atherosclerosis or the degree of atherosclerotic disease. Using ELISAs we measured the plasma levels of neutrophil gelatinase-associated lipocalin (NGAL), neutrophil protease 4 (NP4) as markers for neutrophil activation, tumor necrosis factor alpha (TNF) and soluble TNF receptor-1 (sTNFR-1) as markers of monocyte/macrophage activation in 156 subjects with asymptomatic carotid artery plaque detected at ultrasound examination. Plasma TNF and sTNFR-1 levels were found to correlate with systolic blood pressure (r = 0.32, P < 0.04 and r = 0.22, P < 0.05, respectively). plasma NGAL level to correlate with diastolic blood pressure (r = 0.22; P < 0.005), the plasma levels of sTNFR-1 and NGAL to correlate with age (r = 0.28, P < 0.001 and r = 0.20, P < 0.05, respectively). As compared with non-smokers (n = 112), smokers (n = 43) had higher plasma levels of TNF (2.9 vs. 1.4 microg/l; P < 0.02) and of NP4 (27.5 vs. 23.4 microg/l; P < 0.05). The plasma NGAL level was higher in hypertensive women (n = 7) than in normotensive women (n = 85) (109 vs. 87 microg/l; P < 0.05). We thus demonstrated that, in subjects with asymptomatic early atherosclerosis, the plasma levels of markers of systemic leukocyte activation were correlated with age and blood pressure, and were higher in smokers and hypertensives. These results support the hypothesized relationship between the level of systemic leukocyte activation and risk factors for atherosclerotic vascular disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9180248     DOI: 10.1016/s0021-9150(96)06077-7

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  24 in total

Review 1.  Candidate-based proteomics in the search for biomarkers of cardiovascular disease.

Authors:  Leigh Anderson
Journal:  J Physiol       Date:  2004-12-20       Impact factor: 5.182

2.  Circulating levels of neutrophil gelatinase-associated lipocalin (NGAL) correlate with the presence and severity of preeclampsia.

Authors:  Sun Min Kim; Joong Shin Park; Errol R Norwitz; Hee Jung Jung; Byoung Jae Kim; Chan-Wook Park; Jong Kwan Jun
Journal:  Reprod Sci       Date:  2013-02-25       Impact factor: 3.060

3.  Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: The Rancho Bernardo Study.

Authors:  Lori B Daniels; Elizabeth Barrett-Connor; Paul Clopton; Gail A Laughlin; Joachim H Ix; Alan S Maisel
Journal:  J Am Coll Cardiol       Date:  2012-03-20       Impact factor: 24.094

4.  Advanced glycation endproduct-induced aging of the retinal pigment epithelium and choroid: a comprehensive transcriptional response.

Authors:  Jane Tian; Kazuki Ishibashi; Kazuko Ishibashi; Karen Reiser; Rhonda Grebe; Shyam Biswal; Peter Gehlbach; James T Handa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-04       Impact factor: 11.205

5.  Induction of neutrophil gelatinase-associated lipocalin in vascular injury via activation of nuclear factor-kappaB.

Authors:  De-xiu Bu; Anne-Louise Hemdahl; Anders Gabrielsen; Jonas Fuxe; Chaoyong Zhu; Per Eriksson; Zhong-qun Yan
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

Review 6.  Neutrophil Gelatinase Associated Lipocalin (NGAL) as a Biomarker. Does It Apply in Abdominal Aortic Aneurysms? A Review of Literature.

Authors:  Georgios Karaolanis; Demetrios Moris; Viktoria-Varvara Palla; Euridiki Karanikola; Chris Bakoyiannis; Sotirios Georgopoulos
Journal:  Indian J Surg       Date:  2014-05-16       Impact factor: 0.656

Review 7.  Small lipid-binding proteins in regulating endothelial and vascular functions: focusing on adipocyte fatty acid binding protein and lipocalin-2.

Authors:  Yu Wang
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 8.  Peripheral polymorphonuclear leukocyte activation as a systemic inflammatory response in ischemic stroke.

Authors:  Xiaoye Mo; Ting Li; Guang Ji; Wei Lu; Zhiping Hu
Journal:  Neurol Sci       Date:  2013-04-26       Impact factor: 3.307

9.  Association between inflammatory gene polymorphisms and coronary artery disease in an Indian population.

Authors:  Indranil Banerjee; Umeshwar Pandey; Omer M Hasan; Rashmi Parihar; Vijaya Tripathi; Subramaniam Ganesh
Journal:  J Thromb Thrombolysis       Date:  2007-12-23       Impact factor: 2.300

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.